XML 55 R42.htm IDEA: XBRL DOCUMENT v3.25.2
Restructuring, Impairment, and Related Charges, Net - Schedule of Restructuring Reserve by Type of Cost (Details) - USD ($)
$ in Millions
3 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Restructuring Reserve [Roll Forward]    
Beginning balance $ 126  
Restructuring, impairment, and related charges, net 47 $ 10
Non-cash charges (2)  
Cash payments (83)  
Ending balance 88  
Restructuring liabilities 88  
Operating Segments | U.S. Pharmaceutical    
Restructuring Reserve [Roll Forward]    
Beginning balance 10  
Restructuring, impairment, and related charges, net 1 1
Non-cash charges 0  
Cash payments (2)  
Ending balance 9  
Restructuring liabilities 9  
Operating Segments | Prescription Technology Solutions    
Restructuring Reserve [Roll Forward]    
Beginning balance 1  
Restructuring, impairment, and related charges, net 0 4
Non-cash charges 0  
Cash payments 0  
Ending balance 1  
Restructuring liabilities 1  
Operating Segments | Medical-Surgical Solutions    
Restructuring Reserve [Roll Forward]    
Beginning balance 90  
Restructuring, impairment, and related charges, net 17 3
Non-cash charges 0  
Cash payments (50)  
Ending balance 57  
Restructuring liabilities 57  
Operating Segments | International    
Restructuring Reserve [Roll Forward]    
Beginning balance 1  
Restructuring, impairment, and related charges, net 0 1
Non-cash charges 0  
Cash payments 0  
Ending balance 1  
Restructuring liabilities 1  
Corporate    
Restructuring Reserve [Roll Forward]    
Beginning balance 24  
Restructuring, impairment, and related charges, net 29 $ 1
Non-cash charges (2)  
Cash payments (31)  
Ending balance 20  
Restructuring liabilities 20  
Accrued Liabilities    
Restructuring Reserve [Roll Forward]    
Beginning balance 103  
Ending balance 68  
Restructuring liabilities 68  
Other Non-Current Liabilities    
Restructuring Reserve [Roll Forward]    
Beginning balance 23  
Ending balance 20  
Restructuring liabilities $ 20